Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men

Sex Transm Dis. 2007 Jul;34(7):519-22. doi: 10.1097/01.olq.0000253340.76118.89.

Abstract

Objective: Cellulose sulfate (CS) is a promising vaginal microbicide. Because men will be exposed to the microbicide when engaging in vaginal intercourse, safety and acceptability need to be assessed in men.

Design: This randomized double-blind phase I study assessed the safety and acceptability of seven consecutive daily doses of CS versus KY Jelly in 36 HIV-positive men.

Results: No new or worsening of existing genital findings were observed during the follow-up examination. Mild genital symptoms were reported in 42% of CS users (itching, burning, tingling, testicular pain, dysuria, and warm or cold feeling) and 8% of KY Jelly users.

Conclusion: CS gel applied to the penis was well tolerated in this HIV-positive male population. The itching and burning symptoms were not severe and can be explained by the preservative benzyl alcohol present in the CS gel.

Publication types

  • Clinical Trial, Phase I
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Anti-Infective Agents / administration & dosage*
  • Anti-Infective Agents / adverse effects
  • Cellulose / administration & dosage
  • Cellulose / adverse effects
  • Cellulose / analogs & derivatives
  • Double-Blind Method
  • Gels
  • HIV Infections*
  • Humans
  • Male
  • Middle Aged
  • Penis
  • Sexually Transmitted Diseases / prevention & control*
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Gels
  • Cellulose
  • cellulose sulfate